Related Experiment Video
Updated: Jun 10, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis
1Casey Eye Institute, Oregon Health and Science University, 3303 South West Bond Avenue, Portland, OR 97239, USA. falardea@ohsu.edu
Insights
Giant cell arteritis is a medical emergency requiring prompt diagnosis and treatment to prevent permanent vision loss. Corticosteroids remain the primary treatment for this systemic vasculitis.
Area of Science:
- Rheumatology
- Ophthalmology
- Neurology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis with diverse clinical presentations.
- It poses a significant risk of profound and irreversible visual loss.
- GCA is considered a medical emergency due to potential complications.
Purpose of the Study:
- To emphasize the critical need for prompt diagnosis and treatment of GCA.
- To highlight the importance of early intervention in preventing visual and neurologic deficits.
- To underscore the role of specific diagnostic and therapeutic modalities.
Main Methods:
- Clinical assessment for suspected GCA.
- Performance of temporal artery biopsy for diagnostic confirmation.
- Initiation of corticosteroid therapy as the primary treatment.
Main Results:
- Prompt diagnosis and treatment are crucial for mitigating severe outcomes.
- Temporal artery biopsy is a key diagnostic tool.
- Corticosteroids are the established mainstay of GCA management.
Conclusions:
- Early recognition and management of GCA are imperative.
- Aggressive treatment is necessary to prevent devastating complications like blindness.
- Corticosteroid therapy remains the cornerstone of GCA treatment.
Abstract:
Giant cell arteritis is a systemic vasculitis with a wide clinical spectrum, and it represents a medical emergency. Visual loss is the most feared complication, and when it happens, it tends to be profound and permanent. Prompt diagnosis and treatment are imperative to minimize potentially devastating visual loss and neurologic deficits. A temporal artery biopsy should be performed on every patient in whom the diagnosis is suspected. The mainstay of therapy remains corticosteroids.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Inflammation: Introduction
Rheumatic Heart Disease I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
